subscribeSubscribe
price-trendAsk Us
Eleva Reaches Industrial Production Scale & starts Factor H Clinical Development

Eleva Reaches Industrial Production Scale & starts Factor H Clinical Development
BIOSPACE
14 Sep 2021
Share Share
Sanofi EVP`s Bioverativ blabbing ends in insider trading cases

Sanofi EVP`s Bioverativ blabbing ends in insider trading cases
Angus Liu FIERCE PHARMA
17 Jun 2019
Share Share
List of centrally authorised products requiring a notification of a change for update of annexes

List of centrally authorised products requiring a notification of a change for update of annexes
EMA
12 Oct 2018
Share Share
Advate & Adynovate (Antihemophilic Factor) : Nektar Therapeutics v. Bayer

Advate & Adynovate (Antihemophilic Factor) : Nektar Therapeutics v. Bayer
PATENT LITIGATION
03 Sep 2018
Share Share
Pharma shells out $100B on M&A in 2018 so far: report

Pharma shells out $100B on M&A in 2018 so far: report
Arlene Weintraub FIERCE PHARMA
06 Jul 2018
Share Share
More than $100 Billion Spent on M&A in the First 6 Months of 2018

More than $100 Billion Spent on M&A in the First 6 Months of 2018
Karl Thiel BIOSPACE
05 Jul 2018
Share Share
Adynovate® (Antihemophilic factor) : Bayer HealthCare LLC v. Nektar Therapeutics

Adynovate® (Antihemophilic factor) : Bayer HealthCare LLC v. Nektar Therapeutics
PATENT LITIGATION
13 Mar 2018
Share Share
Shire launches myPKFiT™ for ADVATE® Antihemophilic Factor in the U.S.

Shire launches myPKFiT™ for ADVATE® Antihemophilic Factor in the U.S.
PRESS RELEASE
05 Mar 2018
Share Share
Adynovate®(Antihemophilic ): Bayer Healthcare V. Nektar Therapeutics, Baxalta

Adynovate®(Antihemophilic ): Bayer Healthcare V. Nektar Therapeutics, Baxalta
PATENT LITIGATION
30 Aug 2017
Share Share
CSL Behring receives Health Canada approval for Afstyla to treat hemophilia A

CSL Behring receives Health Canada approval for Afstyla to treat hemophilia A
PHARMABIZ
16 Dec 2016
Share Share